United Therapeutics Corporation

Dedicated to Improving the Lives of PAH Patients

United Therapeutics Corporation was founded by the parents of a child diagnosed with pulmonary arterial hypertension (PAH). Faced with a lack of information, support, and therapy options, they set out on a very personal quest to help change the future for people impacted by PAH. United Therapeutics Corporation is focused on developing effective therapies that fit patients’ lives and providing resources to support and educate patients throughout the journey.

United Therapeutics Corporation offers a range of PAH treatment options and educational resources. We also provide emotional support services for PAH patients and their caregivers. Since United Therapeutics Corporation was founded in 1996, thousands of patients around the world have benefited from our commitment to the PAH community.

Our support of the Pulmonary Hypertension Association (PHA) is helping to build great leaders. With an endowment from United Therapeutics Corporation, the PHA launched the Support Group Leadership Training Institute in 2007. Learn more about training programs for leaders at phassociation.org.

United Therapeutics Corporation is conducting research in new areas that could change the future of PAH treatments. We are proud of how far we’ve come, but we are more excited about what lies ahead. Our ultimate goal is a cure for PAH.

Learn more about United Therapeutics Corporation’s dedication to meeting the needs of PAH patients.

Questions? Call the United Therapeutics Corporation Customer Service Line at 1-877-UNITHER (1-877-864-8437).